Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a large representative health insurance plan in the US

Journal of Medical Economics

Volumn 18, Issue 2, 2015, Pages 106-112

  Slabaugh, S Lane ^a   Curtis, Bradley H ^b   Clore, Gosia ^a   Fu, Haoda ^b   Schuster, Dara P ^b  

^a Formerly of Comprehensive Health Insights Inc   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Cost distribution; Healthcare costs; Medicare Advantage; Quantile regression; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONSUMER; COST CONTROL; DEMOGRAPHY; DIABETES COMPLICATIONS SEVERITY INDEX; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH MAINTENANCE ORGANIZATION; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICARE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT CARE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREFERRED PROVIDER ORGANIZATION; RESOURCE ALLOCATION; SCORING SYSTEM; UNITED STATES; DIABETES MELLITUS, TYPE 2; ECONOMICS; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COMORBIDITY; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH EXPENDITURES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICARE PART C; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84923174905     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/13696998.2014.979292     Document Type: Article

References (18)

1. US Centers for Disease Control and Prevention. Diabetes Report Card 2012. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services, 2012. http://www.cdc.gov/diabetes/pubs/pdf/DiabetesReportCard.pdf. Accessed June 25, 2014
2. American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26:917-32
3. American Diabetes Association. Economic costs of diabetes in the US in 2007. Diabetes Care 2008;31:596-615
4. American Diabetes Association. Economic costs of diabetes in the US in 2012. Diabetes Care 2013;36:1033-46
5. Maguire J, Dhar V. Comparative effectiveness for oral anti-diabetic treatments among newly diagnosed type 2 diabetics: data-driven predictive analytics in healthcare. Heal Syst 2012;2:73-92
6. Li R, Bilik D, Brown MB, et al. Medical costs associated with type 2 diabetes complications and comorbidities. Am J Manag Care 2013;19: 421-430
7. Boyle JP, Thompson TJ, Gregg EW, et al. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and pre-diabetes prevalence. Popul Health Metr 2010;8:29
8. Montgomery DC, Peck EA, Vining GG. Introduction to Linear Regression Analysis. 5th edn. Hoboken, NJ: Wiley, 2012
9. Koenker R. Quantile regression. New York, NY: Cambridge University Press, 2005
10. Chen SL. An introduction to Quantile Regression and the QUANTREG Procedure. Paper 213-30, Statistics and Data Analysis. Cary, NC: SAS Institute, http://www2.sas.com/proceedings/sugi30/213-30.pdf. Accessed June 25, 2014
11. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70
12. Young BA, Lin E, Von Korff M, et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care 2008;14:15-23
13. Chang H-Y, Weiner JP, Richards TM, et al. Validating the adapted Diabetes Complications Severity Index in claims data. Am J Manag Care 2012;18:721-6
14. Hastie T, Tibshirani R, Friedman J. The elements of statistical learning. New York: Springer, 2009
15. Bhattacharyya SK, Else BA. Medical costs of managed care in patients with type 2 diabetes mellitus. Clin Therapeut 1999;21:2131-42
16. Brandle M, Zhou H, Smith BR, et al. The direct medical cost of type 2 diabetes. Diabetes Care 2003;26:2300-4
17. Chen HL, Hsiao FY. Risk of hospitalization and healthcare cost associated with diabetic complication severity index in Taiwan's National Health Insurance Research Database. J Diabetes Complications 2014;28:612-6
18. Dodd AH, Colby MS, Boye KS, et al. Treatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999-2004. Curr Med Res Opin 2009;27:1605-13